"SPEEDING SAFE AND EFFECTIVE CANCER TREATMENTS TO PATIENTS IS OUR ONLY MISSION"
MAY 2016 / BETHESDA, MD

AAADV not only impacts the rate at which oncology drugs are brought to market, but patients afflicted with cancer have been able to appreciate significant advances in their care and survival rates.

Richard Pazdur

Director, Office of Hematology and Oncology Drug Products

U.S. Food and Drug Administration Center for Drug Evaluation and Research

fetishempire.me

Programs

AAADV Workshop

Leaders in clinical and translational cancer research from academia, industry, government and the nonprofit advocacy sector focus on understanding and efficiently negotiating the drug development process.

May 4-6, 2016

Learn More

 

New for 2016

AAADV Scholars

Pre-workshop for Clinical and Translational Investigators

May 3, 2016

Learn More

 
New for 2016

AAADV Fundamentals

In collaboration with Susan G. Komen

Pre-workshop for Patient Advocates

May 3, 2016

Learn More

 

Speakers

 

Subscribe


Please Wait!

Location

Biomarkers Tutorial

ASC_16168-Markers-AAADV-Banner-2016_03

Twitter Feed

buydrugshere.com

TWEET WITH THE HASHTAG #AAADV2016


AAADV Mobile app coming soon for Android and iOS

app-store-imagegoogle-play-image